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Abstract
Prolonged muscle exposure to low PO2 conditions may cause oxidative stress resulting in severe muscular injuries. We
hypothesize that PO2 cycling preconditioning, which involves brief cycles of diaphragmatic muscle exposure to a low
oxygen level (40 Torr) followed by a high oxygen level (550 Torr), can reduce intracellular reactive oxygen species (ROS) as
well as attenuate muscle fatigue in mouse diaphragm under low PO2. Accordingly, dihydrofluorescein (a fluorescent probe)
was used to monitor muscular ROS production in real time with confocal microscopy during a lower PO2 condition. In the
control group with no PO2 cycling, intracellular ROS formation did not appear during the first 15 min of the low PO2 period.
However, after 20 min of low PO2, ROS levels increased significantly by ,30% compared to baseline, and this increase
continued until the end of the 30 min low PO2 condition. Conversely, muscles treated with PO2 cycling showed a complete
absence of enhanced fluorescence emission throughout the entire low PO2 period. Furthermore, PO2 cycling-treated
diaphragm exhibited increased fatigue resistance during prolonged low PO2 period compared to control. Thus, our data
suggest that PO2 cycling mitigates diaphragm fatigue during prolonged low PO2. Although the exact mechanism for this
protection remains to be elucidated, it is likely that through limiting excessive ROS levels, PO2 cycling initiates ROS-related
antioxidant defenses.
Citation: Zuo L, Diaz PT, Chien MT, Roberts WJ, Kishek J, et al. (2014) PO2 Cycling Reduces Diaphragm Fatigue by Attenuating ROS Formation. PLoS ONE 9(10):
e109884. doi:10.1371/journal.pone.0109884
Editor: Xiao Su, Chinese Academy of Sciences, China
Received June 9, 2014; Accepted September 12, 2014; Published October 9, 2014
Copyright:  2014 Zuo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its
Supporting Information files.
Funding: Funding provided by Oakland University General Fund G110, Research Excellence Fund of Biomedical Research, and The Ohio State University-Health
and Rehabilitation Sciences fund 013000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: zuo.4@osu.edu
Introduction
Low oxygen/hypoxic conditions can significantly reduce
skeletal muscle contraction [1]. In normal resting muscle, it has
been reported that skeletal muscles, such as the diaphragm,
produce reactive oxygen species (ROS) including hydrogen
peroxide (H2O2) [2]. However, when the diaphragm is repetitively
stimulated, these muscle fibers generate excessive ROS leading to
oxidative stress with accelerated fatigue development [2]. More-
over, the production of ATP is driven by electron transmission
through mitochondrial complex I to complex IV, creating a
proton gradient across the inner mitochondrial membrane (IMM)
and triggering ATP synthesis [3,4]. Through this mechanism, a
small portion of electrons may leak out of the IMM and react with
adjacent oxygen molecules to produce superoxide anions, H2O2,
and other ROS. Under prolonged low PO2 conditions, the
physiological concentration of O2 is altered which results in
increased uncoupling between O2 and electron flow, ultimately
causing ROS overproduction [5].
A variety of cellular preconditioning pathways associated with
muscular protection have been proposed. For instance, ischemic
preconditioning (IPC), which consists of ischemic-reperfusion
cycles produced by variations in low-high PO2 levels, has been
used to prevent cardiac muscle injuries [6]. In addition, IPC
initiates intracellular protein kinase pathways, resulting in
increased activation of antioxidant enzymes such as catalase [6].
IPC also plays a critical role in protecting the heart against
ischemia-reperfusion injuries by opening mitochondrial ATP
sensitive potassium channels (mKATP) [7]. The mKATP channels
are regulated by several factors, including adenosine, H+, and/or
protein kinase C. Thus, these mediators may partially contribute
to the protective response involved in preconditioning therapies
[8,9]. Similar to IPC, PO2 cycling preconditioning, which consists
of brief periods of lower-higher PO2, significantly protects heart
muscle cells subjected to prolonged ischemia by decreasing ROS-
induced cell death [7,10]. In addition, human studies have shown
that intermittent low oxygen exposure at low altitude significantly
increases an aircraft crew’s adaptation to low oxygen conditions
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experienced at high altitude [11]. Since the method of both IPC
and PO2 cycling preconditioning involves brief periods of low and
high oxygen levels, it is possible that PO2 cycling follows a similar
molecular pathway as IPC. Furthermore, it has been shown that a
protocol consisting of PO2 cycling provides a protective response
against mesenchymal stem cell (MSC) apoptosis through phos-
phorylation of extracellular regulated kinase (ERK1/2) and
protein kinase B (AKT) [12]. Therefore, it is possible that these
signaling factors also may be involved in the molecular mechanism
of PO2 cycling in skeletal muscle.
Moreover, lower PO2 or hypoxic conditions may cause changes
in the cytosolic redox equilibrium, resulting in a rise in NADPH.
The increase subsequently stimulates inositol triphosphate (IP3)
receptor mediated release of Ca2+ from the endoplasmic
reticulum. This release of Ca2+ activates important cell survival
signaling pathways, which may potentially contribute to the
preconditioning response during lower PO2 stress [13]. However,
the redox mechanism of PO2 cycling preconditioning particularly
in respiratory skeletal muscle has not been fully elucidated. The
ultimate importance of the work is to develop treatments for those
who may experience respiratory muscle fatigue. It is likely that
PO2 cycling initiates ROS-related protective responses, particu-
larly in a key muscle of respiration such as the diaphragm, which
must be active throughout life [14].
In this study, we tested the hypothesis that PO2 cycling
preconditioning decreases intramuscular ROS levels and enhances
diaphragm muscle function. Our results demonstrate that PO2
cycling effectively reduces diaphragm fatigue during a prolonged
low PO2 (40 Torr) condition, which is accompanied by decreased
intracellular ROS levels. These findings provide insight into the
molecular redox mechanism of PO2 cycling in diaphragmatic
skeletal muscle exposed to a lower PO2 environment.
Materials and Methods
Animals
Male adult C57BL/6 mice (,20–30 g, average age of ,3 mo.)
were used in accordance with the Ohio State University’s and
Oakland University’s Institutional Laboratory Animal Care and
Use Committee (IACUC). We strictly followed the Guide for the
Care and Use of Laboratory Animals of the National Institutes of
Health and Ethics of Animal Experiments. Mice were anesthetized
via intraperitoneal (IP) injection with a combination of ketamine
(70 mg/kg) and xylazine (10 mg/kg). The diaphragm was quickly
removed from the mouse and muscle strips (,0.5 cm wide,
,1 cm long, 1–2 strips obtained from each mouse) were dissected
from the diaphragm with the corresponding rib attachment and
central tendon. After isolation, the muscle strip was kept in
Ringer’s solution (in mM: 21 NaHCO3, 1.0 MgCl2, 1.2
Na2HPO4, 0.9 Na2SO4, 2.0 CaCl2, 5.9 KCl, 121 NaCl, and
11.5 glucose), at 37uC.
PO2 cycling and muscle function measurement
Function experiments were performed in a contraction chamber
(model 800 MS; Danish Myo Technology, Denmark), with the
central tendon of the muscle strip sutured to a mobile lever, which
was used to adjust the muscle length for optimal performance. The
opposite end of the strip was secured to a force transducer
(detection range 0–1,600 mN). After being mounted, muscle
optimal length (L0) was set as the baseline tension and no
adjustments were made throughout the muscle function experi-
ments. All muscles were electrically stimulated (S48 stimulator;
Grass Technologies, RI) using square-wave pulses (250-ms train
duration, 0.5-ms pulse duration, 70 Hz, 30 V), following previous
skeletal muscle function protocols [15,16]. The A-D board (model
ML826; AD instruments, CO) converted the analog signals to
digital data, and LabChart 7.3.1 software was used to analyze the
function data. The muscle was equilibrated in Ringer’s solution for
20–30 min. During the function experiments, the treated muscle
strips were switched to a Ringer’s solution equilibrated with PO2
of 40 Torr O2 (lower) for 2 min, followed by PO2 of 550 Torr O2
(higher) for 2 min. This PO2 cycle was repeated five times,
followed by a prolonged 30-min 40 Torr PO2 period. During this
exposure, muscle contractility was evaluated, in order to determine
the effect of PO2 cycling on the muscle function. The chamber
solution during lower PO2 was found to be 40 Torr and during
higher PO2, 550 Torr. In the middle of the 40 Torr PO2 period
(from 15–20 min), the muscle was stimulated for 5 min at 37uC
and muscle tension development was recorded. The control group
followed an identical protocol as the experimental group except
for the one intervention of PO2 cycling. Following the removal of
the attached rib bone and excess tendon, the diaphragm was first
air dried which was followed by a 30-min oven drying. The dry
mass was then determined using an analytical balance. To reduce
random effects due to animal variance, all function data were
normalized by dry weight of the muscle strip (mN/mg).
Regarding the H2O2 treatment with PO2 cycling group for low
PO2 contraction measurements, the muscle strips were treated the
same as above except that after PO2 cycling, we added H2O2 into
the muscle contraction solution. Although H2O2 may degrade
rapidly, at sufficient levels, it can enter the cell freely and affect the
intracellular activity [17]. Specifically, the muscle was loaded with
Ringer’s solution with adequate H2O2 (50 mM) for 15 min prior to
the 5-min contractions in low PO2 conditions. In addition, the
time to reach 50% (T50) of the initial tension in contracting
diaphragm muscle during a 5-min low PO2 contraction period was
recorded in control, PO2 cycling, and PO2 cycling + H2O2 groups.
The effect of varying H2O2 dosage on muscle tension
development was evaluated. The muscle strips were prepared in
the same manner as mentioned above. During a high PO2 (550
Torr) period, each muscle strip was equilibrated with Ringer’s
solution for 15 min followed by a 15 min incubation with a
particular dosage of H2O2 (0 mM, 50 mM, 100 mM, 1 mM, to
10 mM, respectively). After incubation, each diaphragm strip was
stimulated for 5 min at 37uC and the muscle tension development
was recorded.
For the H2O2 treatment group with no PO2 cycling for high
PO2 contraction measurements, the muscle strips were exposed to
high PO2 (550 Torr). Each muscle strip had two independent 5-
min contraction periods, which were separated by a 60-min rest
period. The muscle was loaded with H2O2 (50 mM) for 15 min
followed by the first 5-min contractile period. The H2O2 was then
washed out with fresh Ringer’s solution, and the muscle was kept
for a 60-min rest period before a second 5-min contraction bout in
the absence of H2O2. This protocol was also performed in a
blocked order to ensure the statistical value.
Confocal studies
To analyze the effects of PO2 cycling treatment on ROS levels
in superfused diaphragm, confocal microscopy was used to
measure real-time ROS (H2O2) production in both PO2 cycling-
treated and control diaphragm tissue. Specifically, each muscle
strip was loaded with a 40 mM solution of dihydrofluorescein
diacetate (Hfluor-DA; stock in dimethyl sulfoxide; Sigma-Aldrich)
for 30 min. The dye diffused into the intramuscular compartment
and was able to chemically react with intracellular ROS (mainly
H2O2) resulting in enhanced florescence. For statistical purposes,
one muscle strip was taken from each mouse. We used five mice
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for control and five mice for PO2 cycling treatment. A laser scan
confocal microscopy system (Nikon confocal microscope D-Eclipse
C1 system) recorded fluorescent emission signals from the tissue
sample in a glass bottom culture dish (MatTek Corporation,
Ashland, MA) in real time. The treated muscle strips were
mounted and superfused with Ringer’s solution, followed by PO2
cycling treatment, which was a similar method as described above
for the muscle function experiments. To ensure an accurate
oxygen level, the chamber was sealed except for the tubing inlets
containing gas bubbling and superfusate as well as the temperature
probe. The superfusate solution was fully saturated with designat-
ed gas and preheated to ensure the temperature in the chamber
remained at 37uC. The strips were then subjected to a 10-min
baseline period (PO2 of 550 Torr) and a subsequent 30-min 40
Torr PO2 period at 37uC. The control muscles followed the same
protocol except that there was no PO2 cycling treatment. During
the 40-min experimental period (10 min for baseline of 550 Torr
PO2 and 30 min 40 Torr PO2 period), we captured an image
(5126512 pixels) every 5 min and calculated the mean fluores-
cence to determine intramuscular ROS levels. To reduce the
signal-to-noise ratio, each recorded image was an average from
eight sequentially scanned images within 5 s at each time point.
The setup parameters for the confocal imaging system were listed
as follows: laser, argon; pinhole: medium or large; excitation,
488 nm; emission, 535625 nm. The baseline autofluorescence
was kept at a minimum and did not interfere with the ROS signal
in our set-up. To reduce photobleaching or photodamaging, the
laser power was set at ,15% without noticeably sacrificing image
quality. To reduce imaging saturation due to possible excessive
ROS in 40 Torr PO2 conditions, the PMT gain was set as low as
possible from the start of each experiment. In order to verify that
the increased fluorescence signal was due to ROS, a series of
antioxidant experiments were conducted. The glutathione perox-
idase mimic, ebselen (30 mM), which is an effective ROS scavenger
particularly for skeletal muscle tissue [5], was utilized. The animals
were divided into 4 experimental groups, including control, PO2
cycling, ebselen, and PO2 cycling + H2O2. In each experimental
group, five muscle samples were directly isolated from five fresh
isolated diaphragms. For each experiment, we were able to
measure ROS levels from ,8–10 muscle fibers in each image
field.
In preliminary studies, we found that the PO2 cycling protocol
did not change the fluorescence baseline in the current set-up (data
not shown). Each acquired image was analyzed with Adobe
Photoshop element 6.0 and the final images were presented in a
300 DPI resolution with LZW compression.
Statistics
By performing the power analysis on the sample, we defined the
PO2 cycling effect on the skeletal muscle force development as well
as intracellular ROS formation. For instance, we determined the
PO2 cycling effect on multiple groups including control, antiox-
idant (ebselen) treatment and H2O2 application, using the
prospective means across these groups. We derived the power
when the sample size was ,5 or greater mice per group by
calculating the standard deviation. In addition, data were analyzed
using a multi-way ANOVA with the animal as a variable, and
expressed as means 6 SE. The differences between the two
treatments were statistically determined by a series of post-
ANOVA contrast analyses using JMP software (SAS Institute,
Cary, NC). Specifically, the post-ANOVA contrasts involve the
comparison among all the groups of subjects and the display of the
statistical difference between each pair of data. The treated
groups, such as PO2 cycling, antioxidant (ebselen) treatment and
H2O2 application, were used to compare with the control group,
revealing any potential significance. P,0.05 was regarded to be
significant.
Results
Representative confocal images of the same muscular area in
each group are illustrated in Fig. 1. Fluorescence (green color),
which represents ROS levels, increased substantially at the end of
prolonged 40 Torr PO2 period (30 min, Fig. 1B) compared to
baseline in the control group (Fig. 1A). However, after PO2
cycling treatment, fluorescence displayed no significant change at
the end of 40 Torr PO2 (Fig. 1D) when compared to baseline
(Fig. 1C). The disappearance of increased fluorescence emission in
PO2 cycling treatment demonstrated that PO2 cycling effectively
suppressed 40 Torr PO2-induced intracellular ROS levels in the
diaphragm. In addition, ebselen treated muscle strips showed no
fluorescence increase at the end of 40 Torr PO2 exposure
(Fig. 1F). Interestingly, exogenous addition of H2O2 (50 mM)
mitigated the antioxidant effect of PO2 cycling (Fig. 1H).
Grouped data of mean florescence during 40 Torr PO2 are
illustrated in Fig. 2A. At the end of 40 Torr PO2 periods, ROS
levels were elevated from baseline in the control group. However,
in the PO2 cycling group, ROS levels were kept low compared to
control (1.0060.04 RU vs. 1.4860.05 RU; n=5 from five
animals; P,0.05). Furthermore, in the control group, intracellular
ROS elevation did not appear within the first 15 min of 40 Torr
PO2 period. After 20 min, ROS levels were enhanced and these
increases lasted until the end of the 30 min period. Fig. 2B
displayed the intracellular ROS fluorescence rate (RU/min). In
the control group, this rate was close to zero for the first 15 min of
40 Torr PO2, followed by three ROS bursts occurring at 20, 25,
Figure 1. Representative ROS images from Hfluor-loaded
diaphragm tissue. A: control muscle before 40 Torr PO2. B: the same
area of A at the end of 40 Torr PO2. C: PO2 cycling treated muscle before
40 Torr PO2. D: the same area of C at the end of 40 Torr PO2. E: Ebselen
(Eb) treated muscle before 40 Torr PO2. F: the same area of E at the end
of 40 Torr PO2. G: PO2 cycling + H2O2 treated muscle before 40 Torr PO2.
H: the same area of G at the end of 40 Torr PO2.
doi:10.1371/journal.pone.0109884.g001
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and 30 min, represented by positive values shown in Fig. 2B (in
RU/min). The first ROS burst was relatively smaller (,50% less)
compared to the other two larger bursts. However, in PO2 cycling-
treated diaphragm muscles, no ROS burst occurred at 40 Torr
PO2. It is important to note that although Fig. 2B looks similar to
Fig. 2A, they refer to two separate measurements: fluorescence in
Fig. 2A and fluorescence rate in Fig. 2B. In other words, Fig. 2B
shows the mathematical slope of the fluorescence increase/
decrease, indicating how fast the signal changes while Fig. 2A
shows the level or the intensity of fluorescence.
Muscle absolute tension data during 40 Torr PO2 are shown in
Fig. 3. In the control group, the tension (in mN/mg muscle dry
weight) at 0 min and the tension at each subsequent time point
thereafter (1–5 min), was significantly lower than the PO2 cycling
group (n= 5 from five animals, P,0.05), suggesting that PO2
cycling ameliorated skeletal muscle resistance to fatigue during the
40 Torr PO2 period (Fig. 3A). The tension decline rate in PO2
cycling treated muscles markedly slowed down in the first 3 min
compared to control (n = 5 from five animals for each group, P,
0.05, Fig. 3B). However, after 3 min the decline rate of all groups
was similar, indicating that PO2 cycling had no effect on the force
decline rate for later fatigue development. Furthermore, the time
to 50% of the initial tension (T50) from PO2 cycling diaphragm
muscle was significantly prolonged when compared to control
diaphragm (in seconds, 216.2633.0 vs. 99.5610.0; n= 5 from five
animals, P,0.05, Fig. 4). However, this difference disappeared in
the presence of H2O2 in the PO2 cycling + H2O2 group (in
seconds, 117.167.2 vs. 99.5610.0; n = 5 from five animals,
Fig. 4). Maximal diaphragm force was always measured prior to
low PO2 exposure. The corresponding muscle absolute tension
values were reported in Table 1.
We observed that ebselen completely quenched the 40 Torr
PO2-induced ROS signal in the control (Fig. 1E and F, Fig. 2;
n = 4), which demonstrated a similar effect to the PO2 cycling
treatment group (Fig. 1C and D, Fig. 2, n= 5). The addition of a
small amount of H2O2 (50 mM) entirely abolished the PO2 cycling-
induced ROS inhibition effect in the confocal experiments
(Fig. 1G and H). Grouped data are shown in Fig. 2A. Following
15 min from the onset of 40 Torr PO2 period, fluorescence was
significantly higher in PO2 cycling + H2O2 group than the control,
PO2 cycling, and ebselen groups. However, after 30 min of 40
Torr PO2 period, the control group showed higher fluorescence
than the PO2 cycling + H2O2 and ebselen groups, respectively
(n = 5, P,0.05). In Fig. 2B, at 15 min during 40 Torr PO2
periods, there was a larger fluorescent burst in the PO2 cycling +
H2O2 treatment group compared to the other groups. A large
fluorescent burst in the control group occurred ,10 min later
than in the PO2 cycling + H2O2, while there were no bursts in
ebselen treatment groups, respectively (n = 5, P,0.05).
Figure 2. Intracellular ROS fluorescence and fluorescence rate
under 40 Torr PO2. A: averaged fluorescence data recorded in a
relative unit (RU). Data showed intracellular ROS levels from control, PO2
cycling, ebselen (Eb), and PO2 cycling + H2O2 treated diaphragm muscle
(*significantly different from PO2 cycling, P,0.05;
#significantly
different from Eb treatment, P,0.05; {significantly different from
control, P,0.05). B: intracellular ROS burst represented by fluorescence
rate. Data was recorded in a relative unit per min (RU/min) from control,
PO2 cycling, Eb, and PO2 cycling + H2O2 (50 mM) treated diaphragm
muscle under 40 Torr PO2. Fluorescence data was recorded every 5 min
(*significantly different from PO2 cycling, P,0.05;
#significantly
different from Eb treatment, P,0.05; {significantly different from
control, P,0.05).
doi:10.1371/journal.pone.0109884.g002
Figure 3. Muscle tension and tension decline rate data under
40 Torr PO2. A: absolute tension (mN/mg) was recorded for 5 min
from control, PO2 cycling, and PO2 cycling + H2O2 group (*significantly
different from PO2 cycling, P,0.05). B: data showing the tension decline
rate (RU/min) from control, PO2 cycling, and PO2 cycling + H2O2 (50 mM)
muscles during a 5-min contractile period under 40 Torr PO2
(*significantly different from PO2 cycling, P,0.05;
#significantly
different from PO2 cycling + H2O2, P,0.05).
doi:10.1371/journal.pone.0109884.g003
ROS and PO2 Cycling in Skeletal Muscle
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Furthermore, under high PO2 conditions (550 Torr), we
investigated the effect of a small amount of H2O2 (50 mM) on
muscle contraction as shown in Fig. 5 (representative curves) and
Fig. 6 (grouped data). The tension development (mN/mg) and the
tension decline rate (RU/min) at 1–5 min during the 5-min
contraction were recorded in the presence or absence of H2O2.
Both figures clearly illustrate that H2O2 had no marked effect on
muscle function at a level of 50 mM (n= 6).
Moreover, H2O2 dosage experiments were performed in a
range from 0 mM to 10 mM under high PO2 conditions (550 Torr)
as shown in Fig. 7. Muscle tension development was recorded for
the maximal contraction during the baseline period and the initial
and end contractions during the 5-min contraction period. There
was no significant difference between the control group (0 mM)
and the 50 mM group. However, the 100 mM and 1 mM groups
(n = 9 for both groups) did show a significant decrease in muscle
function during the end contraction when compared to both the
control and 50 mM groups (P,0.05). The greatest declines in
muscle tension were observed in the 10 mM group (n = 8) as both
the initial and end contractions showed a marked decrease in
muscle tension development in comparison to all other dosage
groups (P,0.05).
Discussion
The current study provides evidence that the PO2 cycling
preconditioning procedure we used reduces intracellular ROS
levels in respiratory skeletal muscle during prolonged low PO2.
The absolute skeletal muscle tension and T50 were both greater in
the PO2 cycling group than the control group, but the addition of
a small amount of ROS (H2O2) reduced these values to control
levels. However, this amount of ROS was so marginal that it
exerted no significant effect on muscle function during hyperoxia.
Collectively, these data indicate that the protection of PO2 cycling
on the diaphragm is related to the reduced levels of intracellular
ROS signaling molecules.
Dihydrofluorescein (Hfluor) is a highly sensitive intracellular
probe commonly used for fluorescent detection of ROS. Fluores-
cein (Fluor) formation results when Hfluor reacts with ROS [5].
Previous research has shown that Hfluor is much less sensitive to
nitric oxide (NO) compared to its analog dichlorfluorescein
(DCFH) and also shows a higher resistance to photobleaching
than DCFH [5,18,19]. Since it is superior for detecting ROS
(particularly H2O2), it was used in our experiments. Our results
showed that there was no marked ROS formation in the muscle
during the first 15 min of a 40 Torr PO2 period. In the control
group (Fig. 2A), ROS levels were significantly increased after
20 min from the initiation of 40 Torr PO2, which may suggest that
during this timeframe antioxidant defenses were overwhelmed in
diaphragm muscle not treated with PO2 cycling. Moreover, the
completely abolished ROS signals in the antioxidant (ebselen)
treated control group (Fig. 1 and 2), confirms the existence of
ROS, which seems to be quenched by PO2 cycling treatment in
our experiments (Fig. 1 and 2). Interestingly, after PO2 cycling
treatment, extracellular addition of a small amount of ROS
(50 mM H2O2), which has no effect on normal muscle function
(Fig. 5 and 6), completely negated the PO2 cycling effect. These
observations suggest to us that PO2 cycling may be involved in the
initiation of intracellular antioxidant signaling pathways.
Figure 4. Time to reach 50% (T50) of the initial tension in
contracting diaphragm muscle under 40 Torr PO2. A: a typical
chart record illustrating the duration of T50 in a contracting diaphragm
muscle during a 5-min contraction period. B: summarized T50 values
from control, PO2 cycling, and PO2 cycling + H2O2 (50 mM) groups
during the contraction (*significantly different from control, P,0.05;
#significantly different from PO2 cycling + H2O2, P,0.05).
doi:10.1371/journal.pone.0109884.g004
Table 1. % of maximal force prior to low PO2 exposure.
Control (n =5) PO2 cycling (n=5) PO2 cycling + H2O2 (n =5)






Average 6 SE 35.466.56 47.868.58 41.662.84
doi:10.1371/journal.pone.0109884.t001
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It should be noted that the experimental conditions used to
detect ROS are different from those used to evaluate skeletal
muscle function in our settings. ROS detection was performed in
unstimulated muscle, while function was assessed in contracting
muscle, for the following reasons: 1) Due to large motion artifact, it
is extremely difficult to perform muscle function experiments
under confocal microscopy; 2) The muscle function experiment is
focused on measurement of maximal force and time to fatigue.
However, the confocal experiment is primarily designed to
determine intracellular ROS levels in the muscle.
Evidence has shown that PO2 cycling triggers the expression of
superoxide dismutase (SOD), an endogenous antioxidant, which
may further contribute to reduced ROS levels [7,10,20]. This is
highly consistent with our observations of reduced ROS level in
PO2 cycling treated skeletal muscle. Similar to heart studies which
show that both IPC and PO2 cycling are mediated by ROS [7],
intracellular ROS levels were also critical for PO2 cycling efficacy
in diaphragm muscle. There is a potential concern that PO2
cycling could have altered mitochondrial function and integrity.
However, our muscle function data (Fig. 3 and 4) suggest that
fatigue resistance in PO2 cycling treated mouse diaphragm muscle
was substantially greater than that of control muscle. Thus, it is
likely that mitochondrial activity was not negatively altered by
PO2 cycling treatment. Although in the current study design we
are unable to determine whether PO2 cycling treatment causes
decreased ROS production or increased antioxidant scavenging, it
is likely that there is a specific redox mechanism that suppresses
ROS generation during prolonged respiratory muscle exposure to
the 40 Torr PO2. The detailed mechanism associated with PO2
cycling protection, however, is still unclear and requires further
study. In addition, based on a similar previous study of PO2 levels
in myocytes, 40–550 Torr PO2 was an effective setting to initiate
intramuscular redox changes in skeletal muscle [21,22].
Interestingly, we noticed that at 15 min during the 40 Torr PO2
period, ROS levels were significantly higher in the PO2 cycling +
H2O2 group compared to the other groups; yet, at 30 min, the
control group showed a higher ROS level than the PO2 cycling +
H2O2 group (Fig. 2A). This suggests that the two treatment plans
stimulate a time-dependent intracellular ROS formation mecha-
nism. In addition, we evaluated the ROS generation rate, defined
as a ROS burst and represented by the fluorescence rate, as shown
in Fig. 2B. H2O2 addition after PO2 cycling treatment induced the
first ROS burst at 15 min under the 40 Torr PO2 conditions,
which occurred ,10 min earlier than a large ROS burst in the
control group. Collectively, these observations suggest a faster
diffusion of extracellular ROS (H2O2) into the intramuscular
compartment, compared to the intracellular ROS generation in
the control muscle. However at a later time (after 25 min during
low PO2), the control muscle showed a higher ROS formation rate
than the PO2 cycling + H2O2 group. This could be due to leakage
of H2O2 into the perfusate. Nevertheless, these data further
demonstrate a potential antioxidant-like effect exerted by PO2
cycling, and this effect can be disturbed by a small addition of
Figure 5. Representative contraction curves showing the effect of H2O2 (50 mM) on the muscle contraction during high PO2 in a
blocked order. A: H2O2 was added 15 min prior to the first 5-min contractile period followed by a H2O2 washout and 60 min rest period before the
second 5- min contractile period in the absence of H2O2. B: The first 5-min contraction in the absence of H2O2 was followed by the second 5-min
contractile period in the presence of H2O2.
doi:10.1371/journal.pone.0109884.g005
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ROS, which was not sufficient to influence muscle contractility
(Fig. 5 and 6).
Moreover, it is suggested that PO2 cycling mitigates fatigue
within the diagram during hypoxia. Although the exact mecha-
nism by which this occurs is unclear, it is likely that ROS play a
significant role. Accordingly, our data (Fig. 1 and 2) suggest that
low levels of ROS negate the benefits of PO2 cycling and may be
involved in other signaling events, including antioxidant cascades.
Figures 5 and 6 illustrate the relationship between ROS level and
muscular force generation. These results are supported by
previous studies in which it was concluded that low levels of
H2O2 may work more towards signaling pathways since they do
not directly impact force generation in the muscle [23,24]. Further
research into the effect of both ROS and PO2 cycling on
diaphragm force generation and related muscular mechanisms
may lead to potential therapies to mitigate muscle fatigue during
hypoxia.
The H2O2 dosage experiments (Fig. 7) on the diaphragm
function suggest that high levels of ROS (H2O2) such as at 1 mM
or 10 mM levels markedly reduce muscle function; however, lower
levels of ROS, such as 50 mM, do not compromise muscle function
as compared to control. In addition, our confocal experiments
have clearly shown that this low level of ROS (50 mM) minimized
the PO2 cycling effect confirming that rather than damaging
muscle directly, low levels of ROS may be a potential mediator for
the signaling events involved in PO2 cycling preconditioning.
There are a number of intracellular sources of ROS in skeletal
muscle, including the mitochondria, xanthine oxidase (XO),
peroxisomes, and NADPH oxidase [25]. For example, under
respiratory stress, such as ischemia or low PO2/hypoxia, xanthine
dehydrogenase converts to XO, which is subsequently released
into circulation and produces ROS [22,25]. In skeletal muscle
myocytes, NADPH oxidase is another likely candidate for ROS
formation during hypoxic stress during injuries [23]. Additionally,
the mitochondria produce low levels of superoxide anion under
normal conditions [26], but in the lack of oxygen, the mitochon-
dria experience excessive oxidant production [5,26,27]. Accord-
ingly in such a condition, the mitochondria function as a source of
increased level of superoxide, one of the common precursors to
most ROS. This increase in intracellular ROS could potentially
overwhelm natural antioxidant defense systems, leading to
impaired muscle function [2,28–30]. Our data (Fig. 2B) showed
that three ROS oxidative bursts (represented by positive rate
values) occurred after 15 min of the 40 Torr period in the control
muscle, which may indicate that intracellular antioxidant defenses
have a 15 min effective period until they are eventually negated by
subsequent ROS formation. This timeframe is within the regular
activation time range of mitochondrial antioxidant enzymes
[30,31]. Therefore, both XO and mitochondria are possible
sources of ROS in this study.
Moreover, our findings have shown considerable evidence
regarding the protective effects of PO2 cycling training on skeletal
muscle function (Fig. 3A). During the middle of the 40 Torr PO2
period, the initial tension of the PO2 cycling treated muscle strips
was higher than that of control, and this trend kept increasing to
,4 fold greater than control from 1- to 5-min suggesting that PO2
cycling progressively alleviated muscle fatigue. However, after
H2O2 was loaded into the muscle at a relatively low dosage (Fig. 5
and 6), the protection from PO2 cycling was diminished. This
supports that the ROS signaling molecules may possibly play a
negative role in the PO2 cycling mechanism. PO2 cycling
markedly reduced the tension decline rate at both 1-, 2- and 3-
min from the initial contraction compared to control. These rate
differences were minimized at 4- and 5-min, respectively. The
addition of H2O2 also significantly interrupted the PO2 cycling
effect on the tension decline rate at 2- and 3-min in the middle of
the 40 Torr PO2 period (Fig. 3B), confirming that ROS signaling
Figure 6. Grouped data showing the effect of H2O2 (50 mM) on
the muscle contraction during high PO2 in a blocked order. A:
Tension development (mN/mg) at 1–5 min during the 5-min contrac-
tion period in the presence vs. absence of H2O2. B: Tension decline rate
(RU/min) during the 5- min contraction period at 1–5 min in the
presence vs. absence of H2O2.
doi:10.1371/journal.pone.0109884.g006
Figure 7. Grouped data showing the effect of varying H2O2
dosage on muscle tension development during high PO2. Data
showing the muscle tension development (mN/mg) during the H2O2
dosage treatments in mouse diaphragm strips [0 mM (control), 50 mM,
100 mM, 1 mM and 10 mM] in high PO2 (550 Torr). *Significantly
different from control (P,0.05). #Significantly different from 50 mM
H2O2 (P,0.05).
{Significantly different from 100 mM H2O2 (P,0.05).
`Significantly different from 1 mM H2O2 (P,0.05).
doi:10.1371/journal.pone.0109884.g007
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molecules adversely affect PO2 cycling pathways. A possible
correlation among PO2 cycling, muscle fatigue and ROS implies
that PO2 cycling is able to boost muscle contractility during
fatigue, which is consistent with Clanton’s and Reid’s results
[1,32]. Specifically, PO2 cycling could result in a gradual increase
in the production of endogenous antioxidant enzymes, allocating
the additional antioxidants to serve as a ‘‘reservoir’’ that can be
promptly accessed in response to spontaneous exposure to stressful
conditions. This idea is consistent with previous research
suggesting that PO2 cycling significantly increases the expression
level of intramuscular antioxidants such as SOD [7].
Previous research has shown that the intramuscular PO2 during
strenuous exercise is ,4 Torr, while ,30 Torr conditions are seen
in resting muscle [33]. In the current research, we created a
relatively lower PO2 condition by equilibrating 40 Torr PO2 and a
hyperoxic condition with 550 Torr based on previous studies in
skeletal muscle [5,15,21,34]. However, the intracellular PO2 was
difficult to determine under our experimental set-up, particularly
in a contracting muscle with marked motion. During exhaustive
exercise, skeletal muscle conditions fluctuate between higher PO2
and lower PO2, which frequently occur especially during high
intensity interval trainings. This cycling in intracellular oxygen
exerts an intrinsic preconditioning effect, similar to the PO2
cycling protocol implemented in our studies. Additionally, it has
been shown that increased levels of catalase and SOD are
expressed in skeletal muscle during exercise training, resulting in a
reduction of ROS level and oxidative stress [35–38]. Similar to
exercise training, PO2 cycling therapy may be an alternative
method for increasing muscular endurance. Moreover, it is worth
noting that a small amount of ROS (50 mMH2O2) has no effect on
normal muscle function (Fig. 5 and 6). However, this dosage
completely abolished the PO2 cycling protection in low PO2
conditions (Fig. 3). The exact mechanism of this response is still
unknown, which will be an area of future studies.
Some limitations appear in our study. First, we are unable to
determine whether 40 Torr in the solution can cause intramus-
cular hypoxia. Second, it is possible that our PO2 cycling protocol,
by itself, can directly affect intracellular ROS and muscle fatigue
without additional mediators. Third, it is difficult to measure the
exact intracellular PO2 level in a functioning diaphragm. This is
mainly because of a marked O2 diffusion gradient across the
multiple layers of diaphragm tissue. Although previous research
has shown that in a similar condition to 40 Torr PO2, intracellular
levels of NADH in the diaphragm significantly increase [5], it is
not clear whether 40 Torr PO2 in the superfusate can cause the
intracellular compartments hypoxic. Lastly, since O2 cannot
transport across the different layers equally in the whole muscle,
it is more likely that a hypoxic condition may occur in the core of
the muscle than the peripheral region [39]. In addition,
intracellular PO2 in skeletal muscle is ,10 Torr at rest, but it
quickly drops to 3–5 Torr during intense exercise [40]. It is likely
that the transition between 550 Torr to 40 Torr triggers
mismatches of oxygen supply to the diaphragm, which may be
sufficient to induce a transient ROS formation as described in our
earlier research [5]. Our study demonstrated that intracellular
ROS is elevated in single myofibers during a similar PO2
condition [21]. Interestingly, this level of oxygen (3–5 Torr) is
regarded as normal for exercising human muscles [33]. Precisely
controlling the intramuscular O2 condition within the whole
muscle preparation is highly challenging and therefore should be
the focus of future research.
Perspectives and Significance
This study demonstrates that PO2 cycling mediates beneficial
responses through reducing intracellular ROS levels in respiratory
muscle. PO2 cycling is a drug-free treatment that possibly
stimulates the diaphragm to activate its own antioxidant defense
systems to resist fatigue development. This may be an effective
method for enhancing muscular endurance. In addition, the
current in vitro study provides a redox perspective into mouse
respiratory muscle under optimal preconditions.
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